Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ICU Medical, Inc. - Common Stock (NQ:ICUI)

152.16 +5.56 (+3.79%)
Streaming Delayed Price Updated: 12:22 PM EDT, Jul 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about ICU Medical, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali... 
Via StockStory
News headline image
ICU Medical (ICUI): Buy, Sell, or Hold Post Q1 Earnings?
ICU Medical has been treading water for the past six months, recording a small loss of 3.3% while holding steady at $142.98. The stock also fell short of the... 
Via StockStory
Topics Economy
News headline image
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a... 
Via StockStory
News headline image
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient... 
Via StockStory
ICU Medical Inc (NASDAQ:ICUI) Beats Q1 2026 Earnings Estimates as Core Segments Show Growth ↗
Via Chartmill
ICU Medical Inc (NASDAQ:ICUI) Reports Mixed Q4 2025 Results, Beats EPS Estimates Amid Revenue Decline ↗
Via Chartmill
News headline image
ICU Medical's General Counsel Sells — The Smiths Integration Is Almost Done, the Proof Isn'tICU Medical's General Counsel Sells — The Smiths Integration Is still playing out. ↗
This infusion therapy specialist reported a notable insider sale as shares continue to lag over the past year. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
2 Small-Cap Stocks with Solid Fundamentals and 1 Facing Headwinds
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
5 Must-Read Analyst Questions From ICU Medical’s Q1 Earnings Call
ICU Medical’s first quarter results in 2026 were marked by outperformance against Wall Street expectations, with revenue and non-GAAP earnings per share both... 
Via StockStory
Topics Earnings
News headline image
2 Profitable Stocks with Exciting Potential and 1 We Turn Down
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
ICU Medical (ICUI) Q1 2026 Earnings Transcript ↗
ICU Medical (ICUI) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
ICUI Q1 Deep Dive: Infusion Systems and Consumables Offset Vital Care Weakness
Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 12.3% year on year... 
Via StockStory
Topics World Trade
News headline image
ICU Medical (NASDAQ:ICUI) Exceeds Q1 CY2026 Expectations
Medical device company ICU Medical (NASDAQ:ICUI) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 11.6% year on year to $530.2 million... 
Via StockStory
Topics Artificial Intelligence
News headline image
ICU Medical Earnings: What To Look For From ICUI
Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results this Thursday after the bell. Here’s what you need to know. ICU Medical beat analy... 
Via StockStory
News headline image
3 Reasons to Avoid ICUI and 1 Stock to Buy Instead
ICU Medical has been treading water for the past six months, recording a small return of 2.8% while holding steady at $120.94. Is now the time to buy ICU Med... 
Via StockStory
News headline image
Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Teardown: ICU Medical (NASDAQ:ICUI) Vs The Rest
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at ICU Medical (NASDAQ:ICUI) and... 
Via StockStory
News headline image
1 Small-Cap Stock to Keep an Eye On and 2 Facing Challenges
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and... 
Via StockStory
Topics Credit Cards
News headline image
3 Profitable Stocks We Keep Off Our Radar
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
Topics Energy
News headline image
2 Healthcare Stocks with Exciting Potential and 1 We Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
Integra LifeSciences, GE HealthCare, Bausch + Lomb, ICU Medical, and Universal Health Services Shares Are Falling, What You Need To Know
Via StockStory
Topics Earnings Economy
News headline image
ICU Medical’s (NASDAQ:ICUI) Q4 CY2025: Beats On Revenue
Medical device company ICU Medical (NASDAQ:ICUI) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, but sales fell by 13% year on year to $540.7 million. Its non-GAAP profit of $1.91... 
Via StockStory
News headline image
What To Expect From ICU Medical’s (ICUI) Q4 Earnings
Medical device company ICU Medical (NASDAQ:ICUI) will be reporting earnings this Thursday after the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
News headline image
Baxter International (BAX) Deep Dive: Navigating the 16% Plunge and a New Strategic Era
On February 16, 2026, the mood surrounding Baxter International (NYSE: BAX) is one of cautious sobriety following a seismic shift in investor confidence. Long regarded as a defensive staple of the... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
1 of Wall Street’s Favorite Stock on Our Buy List and 2 We Find Risky
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
News headline image
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
News headline image
1 Russell 2000 Stock to Target This Week and 2 We Find Risky
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
News headline image
Baxter International (BAX) in 2025: A Deep Dive into the Transformation of a MedTech Giant
As of December 26, 2025, Baxter International Inc. (NYSE: BAX) stands at a pivotal crossroads in its nearly century-long history. Long considered a defensive "blue-chip" staple of the healthcare... 
Via PredictStreet
Topics Economy Emissions Product Recall
News headline image
3 Small-Cap Stocks We Think Twice About
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stock to Target This Week and 2 We Question
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because... 
Via StockStory
News headline image
3 Reasons to Sell ICUI and 1 Stock to Buy Instead
ICU Medical trades at $148.44 per share and has stayed right on track with the overall market, gaining 11.4% over the last six months. At the same time, the S&P 500 has returned 13.1%. 
Via StockStory
Topics Stocks
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.